From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient

The past decades have seen tremendous progress on elucidating mechanisms leading to acute coronary syndrome and sudden cardiac death. Pathology and imaging studies have identified features of coronary atherosclerosis that precede acute coronary events. However, many factors influence the risk of adv...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology Vol. 74; no. 12; pp. 1582 - 1593
Main Authors: Arbab-Zadeh, Armin, Fuster, Valentin
Format: Journal Article
Language:English
Published: Elsevier Inc 01-09-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The past decades have seen tremendous progress on elucidating mechanisms leading to acute coronary syndrome and sudden cardiac death. Pathology and imaging studies have identified features of coronary atherosclerosis that precede acute coronary events. However, many factors influence the risk of adverse events from coronary atherosclerotic disease and available data support our transition from focusing on individual “vulnerable plaque,” coronary arterial stenosis, and inducible myocardial ischemia to understanding coronary heart disease as multifactorial, chronic disease. The concept of the vulnerable patient has evolved, with the atheroma burden, its metabolic activity, and the disposition to vascular thrombosis building a platform for assessing central aspects of coronary heart disease. In turn, this model has directed us to a focus on controlling the activity of atherosclerotic disease and on modifying the susceptibility of vascular thrombosis which has led to reduced morbidity and mortality from coronary heart disease. [Display omitted] •The evaluation and management of patients with coronary heart disease is in transition.•A comprehensive approach to patients with coronary heart disease is replacing a lesion-focused strategy.•Research over the past 4 decades has strengthened the case for prevention and medical therapy as central interventions in patients with coronary heart disease.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2019.07.062